NCT01211769 arm group f7c9efb7aa2b232304c1b64781dc0b54 [clinicaltrials_resource:NCT01211769/arm-group/f7c9efb7aa2b232304c1b64781dc0b54]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01211769 arm group f7c9efb7aa2b232304c1b64781dc0b54 [clinicaltrials_resource:NCT01211769/arm-group/f7c9efb7aa2b232304c1b64781dc0b54]
Bio2RDF identifier
NCT01211769/arm-group/f7c9efb7aa2b232304c1b64781dc0b54
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... c9efb7aa2b232304c1b64781dc0b54
description [clinicaltrials_vocabulary:description]
Polyunsaturated fatty acids (P ......
Naltrexone chlorhydrate 50 mg
identifier
clinicaltrials_resource:NCT01211769/arm-group/f7c9efb7aa2b232304c1b64781dc0b54
title
NCT01211769 arm group f7c9efb7aa2b232304c1b64781dc0b54
@en
type
label
NCT01211769 arm group f7c9efb7 ...... 9efb7aa2b232304c1b64781dc0b54]
@en